U.S., EU, India, S.Africa reach consensus on COVID vaccine IP waiver -sources
Vials labelled “AstraZeneca, Johnson & Johnson, Pfizer, Moderna COVID-19 Vaccine” are seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/IllustrationRegister now for FREE unlimited access to Reuters.comWASHINGTON/GENEVA March 15 (Reuters) – The United States, European Union, India and South Africa have reached a consensus on key elements of a long-sought intellectual property waiver for…Continue Reading






